Category: BiometSyndicate content

ZMH set to acquire EU approval for $13B Biomet deal | The week in medtech M&A

March 25, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: EU to clear Zimmer's $13B Biomet deal; Philips mulls 2016 IPO for lighting biz as bidding war heats up; Heraeus acquires guidewire maker NeoMetrics; Pyott out after Actavis closes $70B Allergan buyout; Australian PE shop acquires Simplify Medical

Report: EU to clear Zimmer's $13B Biomet deal

March 18, 2015 by MassDevice

Japan OKs $13B Zimmer-Biomet merger

March 25, 2015 by Brad Perriello

Anti-trust regulators in Japan approve the pending, $13 billion merger of orthopedics giants Zimmer Holdings and Biomet.

Japan OKs $13B Zimmer-Biomet merger

BSX faces $50m gender suit | Medtech legal news for the week of March 23, 2015

March 23, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Sales reps level $50m sex discrimination suit against Boston Scientific; Zimmer chooses new bellwethers in NexGen knee implant MDL; Boston Scientific executive's killer gets 17 years; Federal appeals court upholds Smith & Nephew's $85m win over Arthrex; Feds extend Biomet's deferred prosecution deal for another year

Sales reps level $50m sex discrimination suit against Boston Scientific

March 19, 2015 by Brad Perriello

Zimmer touts 1st reverse shoulder replacement

March 20, 2015 by Mark Hollmer

Zimmer touts the 1st reverse shoulder replacement in the U.S. using its Vivacit-E liner with a Trabecular Metal implant.

Zimmer touts 1st reverse shoulder replacement

Zimmer (NYSE:ZMH) is touting the 1st reverse shoulder replacement in the U.S. using its Vivacit-E Liner for the Trabecular Metal reverse shoulder system.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: EU to clear Zimmer's $13B Biomet deal

March 18, 2015 by MassDevice

Anti-trust regulators are reportedly set to approve Zimmer's $13 billion acquisition of cross-town rival Biomet.

Report: EU to clear Zimmer's $13B Biomet deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Feds extend Biomet's deferred prosecution deal for another year

March 18, 2015 by Brad Perriello

The U.S. Justice Dept. extends a deferred prosecution agreement with Biomet for another year, after the orthopedics company last year said it uncovered 'improprieties' by employees in Brazil and Mexico.

Feds extend Biomet's deferred prosecution deal for another year

Biomet said yesterday that the U.S. Justice Dept. extended by a year the deferred prosecution agreement reached in 2012 over alleged violations of the Foreign Corrupt Practices Act.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ZMH to float $7.7B debt to acquire Biomet | The week in medtech M&A

March 18, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Zimmer to float $7.7B debt to acquire Biomet; Becton Dickinson's $12B CareFusion buyout set to close tomorrow; Private equity shops battle for Philips' legacy lighting biz; Digirad acquires mobile-imaging group MD Office Solutions; Becton Dickinson closes $12B CareFusion buyout

Zimmer to float $7.7B debt to acquire Biomet

March 11, 2015 by Brad Perriello